Taek Won Kang
Papers
1
Total Citations
2
H-Index
1
About
Dr. Taek Won Kang is a urologic oncologist whose research centers on the interplay between body composition and prostate cancer outcomes. His most-cited work, a multi-center study from 2021, investigates how pre-operative sarcopenia—measured via the internal obturator muscle mass index on MRI—impacts biochemical recurrence following radical prostatectomy. This contribution addresses a critical gap in the literature, as the relationship between skeletal muscle loss and prostate cancer prognosis remains poorly understood. By demonstrating that muscle mass metrics can serve as predictive biomarkers, Dr. Kang’s research bridges radiology and oncology, offering clinicians a novel tool for risk stratification. With 2 citations, this study has already informed subsequent investigations into sarcopenia’s role in cancer survival. Dr. Kang’s work exemplifies the growing importance of frailty assessment in surgical planning, positioning him at the forefront of personalized urologic care. His findings encourage further exploration of how pre-operative conditioning might improve long-term outcomes for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1